RxElite, Inc.
RXEI
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Revenue | 468.13% | 139.05% | -23.60% | -80.16% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 468.13% | 139.05% | -23.60% | -80.16% | -- |
| Cost of Revenue | 526.62% | 134.30% | -28.16% | -80.77% | -- |
| Gross Profit | 201.76% | 190.11% | 127.26% | -52.14% | -- |
| SG&A Expenses | 109.65% | 155.47% | 116.36% | 128.83% | -- |
| Depreciation & Amortization | 374.17% | 364.18% | 283.25% | 110.13% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 123.04% | 116.27% | 37.24% | -18.13% | -- |
| Operating Income | -51.86% | -104.71% | -113.54% | -187.99% | -- |
| Income Before Tax | -102.86% | -2,866.50% | -471.18% | -328.08% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -102.86% | -2,866.50% | -471.18% | -328.08% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -102.86% | -2,866.50% | -471.18% | -328.08% | -- |
| EBIT | -51.86% | -104.71% | -113.54% | -187.99% | -- |
| EBITDA | -33.66% | -87.91% | -103.05% | -183.98% | -- |
| EPS Basic | 19.16% | -157.39% | -174.45% | -170.38% | -- |
| Normalized Basic EPS | -6.14% | -2.43% | 18.72% | 14.66% | -- |
| EPS Diluted | 19.16% | -213.82% | -232.07% | -220.14% | -- |
| Normalized Diluted EPS | -6.14% | -8.00% | 15.20% | 10.61% | -- |
| Average Basic Shares Outstanding | 130.70% | 209.70% | 223.90% | 209.97% | -- |
| Average Diluted Shares Outstanding | 130.70% | 194.16% | 203.46% | 185.78% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |